← Back
Data updated: Mar 10, 2026
Lundbeck Seattle BioPharmaceuticals, Inc.
Neurology
Lundbeck Seattle BioPharmaceuticals, Inc. is a biotechnology company focused on Neurology.
2020
Since
1
Drugs
-
Trials
4
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
VYEPTI 2025-10-22
Efficacy
VYEPTI 2025-08-18
Efficacy
VYEPTI 2025-03-21
Labeling
VYEPTI 2025-03-21
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2020-02-21
- Latest
- 2025-10-22
- Applications
- 1